Moreover, the ZFP36/PRC1 regulatory axis has been proposed as a potential therapeutic target, as restoring ZFP36 expression attenuates tumor proliferation and enhances chemosensitivity to agents such as 5-fluorouracil [73]. Here, PRC1 is linked to neoplasm.